• Home
  • c-Src activation mediates erlotinib resistance in head and neck cancer by stimulating c-Met.

c-Src activation mediates erlotinib resistance in head and neck cancer by stimulating c-Met.

Author List
Stabile LP, He G, Lui VW, Thomas S, Henry C, Gubish CT, Joyce S, Quesnelle KM, Siegfried JM, Grandis JR
Publication
Clinical cancer research : an official journal of the American Association for Cancer Research
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1167522
Publication Year
2012
PubMed ID
23213056
Publication Title
Stabile LP, He G, Lui VW, Thomas S, Henry C, Gubish CT, Joyce S, Quesnelle KM, Siegfried JM, Grandis JR. c-Src activation mediates erlotinib resistance in head and neck cancer by stimulating c-Met. Clin Cancer Res. 2013 Jan 15; 19(2):380-92.